Hazardous alcohol use among patients with psychiatric disorders: Findings from phosphatidylethanol (PEth) screening in healthcare

Identifying hazardous alcohol use among patients with psychiatric disorders is important for improving treatment outcomes. This study aimed to describe the prevalence of hazardous alcohol use across 20 psychiatric diagnoses using phosphatidylethanol (PEth) blood sampling. We conducted a cross-sectional analysis of PEth samples collected between 2017 and 2023 from a regional Swedish healthcare database, linked to clinician-assessed psychiatric diagnoses. Participants were adults (≥18 years) with…

via https://pubmed.ncbi.nlm.nih.gov/40976101/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1HYeX0emtvYgH07Wkz0a8n9otrdMd-JIklc_uo0I5vh1u9WMEy&fc=None&ff=20250922010805&v=2.18.0.post9+e462414